.BETA.-D-GLUCOPYRANOSIDURONIC ACID, 5-((1R)-2-((5,6-DIETHYL-2,3-DIHYDRO-1H-INDEN-2-YL)AMINO)-1-HYDROXYETHYL)-1,2-DIHYDRO-2-OXO-8-QUINOLINYL
UNII S3YCF4P4TA

Substance Identification & Data

This profile provides standardized clinical and technical data for .beta.-d-glucopyranosiduronic Acid, 5-((1r)-2-((5,6-diethyl-2,3-dihydro-1h-inden-2-yl)amino)-1-hydroxyethyl)-1,2-dihydro-2-oxo-8-quinolinyl, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S3YCF4P4TA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1446354-20-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

S3YCF4P4TA

CAS Registry Number

1446354-20-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

.BETA.-D-GLUCOPYRANOSIDURONIC ACID, 5-((1R)-2-((5,6-DIETHYL-2,3-DIHYDRO-1H-INDEN-2-YL)AMINO)-1-HYDROXYETHYL)-1,2-DIHYDRO-2-OXO-8-QUINOLINYL

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C30H36N2O9

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

QTEUXTDFPHJNHA-IQEQWHAESA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

46887146

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c12c([nH]c(=O)cc1)c(ccc2[C@H](CNC3Cc4c(C3)cc(c(c4)CC)CC)O)O[C@H]5[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(=O)O)O5

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for .beta.-d-glucopyranosiduronic Acid, 5-((1r)-2-((5,6-diethyl-2,3-dihydro-1h-inden-2-yl)amino)-1-hydroxyethyl)-1,2-dihydro-2-oxo-8-quinolinyl. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.